Under-utilization of statins among people with HIV who were aged 40 years or older

From June 2022 to April 2023, 1629 HIV-positive participants were assessed for the risk of atherosclerotic cardiovascular disease (ASCVD). The 10-year ASCVD risk of <5 %, 5 % to <7.5 %, ≥7.5 % to <20 % and ≥20 % were 59.9 %, 14.4 %, 20.7 % and 5.0 %, respectively; 440 (27.0 %) participants...

Full description

Bibliographic Details
Main Authors:	Pei-Ying Wu, Hsin-Yun Sun, Yu-Shan Huang, Wang-Da Liu, Kuan-Yin Lin, Yu-Zhen Luo, Hsi-Yen Chang, Ling-Ya Chen, Yi-Ting Chen, Chien-Ching Hung
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Journal of Microbiology, Immunology and Infection
Subjects:	Lipid-lowering agent Dyslipidemia Major adverse cardiovascular event Atherosclerotic cardiovascular disease Diabetes mellitus Non-communicable disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S1684118224000045

Internet

http://www.sciencedirect.com/science/article/pii/S1684118224000045

Under-utilization of statins among people with HIV who were aged 40 years or older

Internet

Similar Items